Literature DB >> 26830253

Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS).

Nisha Bansal1, Ronit Katz2, Stephen Seliger3, Christopher DeFilippi3, Mark J Sarnak4, Joseph A Delaney2, Robert Christenson3, Ian H de Boer2, Bryan Kestenbaum2, Cassianne Robinson-Cohen2, Joachim H Ix5, Michael G Shlipak6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26830253      PMCID： PMC6636633          DOI： 10.1053/j.ajkd.2015.12.022

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  16 in total

1.  sST2 as a novel biomarker for the prediction of in-hospital mortality after coronary artery bypass grafting.

Authors:  Meagan E Stabler; Michael E Rezaee; Devin M Parker; Todd A MacKenzie; Andrew R Bohm; Anthony W DiScipio; David J Malenka; Jeremiah R Brown
Journal:  Biomarkers       Date:  2019-01-11       Impact factor: 2.658

2.  Biomarkers associated with 30-day readmission and mortality after pediatric congenital heart surgery.

Authors:  Devin M Parker; Allen D Everett; Meagan E Stabler; Luca Vricella; Marshall L Jacobs; Jeffrey P Jacobs; Heather Thiessen-Philbrook; Chirag R Parikh; Jeremiah R Brown
Journal:  J Card Surg       Date:  2019-04-03       Impact factor: 1.620

3.  Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.

Authors:  Nisha Bansal; Leila Zelnick; Michael G Shlipak; Amanda Anderson; Robert Christenson; Rajat Deo; Christopher deFilippi; Harold Feldman; James Lash; Jiang He; John Kusek; Bonnie Ky; Stephen Seliger; Elsayed Z Soliman; Alan S Go
Journal:  Clin Chem       Date:  2019-10-02       Impact factor: 8.327

4.  Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery.

Authors:  Devin M Parker; Allen D Everett; Meagan E Stabler; Luca Vricella; Marshall L Jacobs; Jeffrey P Jacobs; Chirag R Parikh; Sara K Pasquali; Jeremiah R Brown
Journal:  Ann Thorac Surg       Date:  2019-07-16       Impact factor: 4.330

5.  Galectin-3 as a Predictor of Long-term Survival After Isolated Coronary Artery Bypass Grafting Surgery.

Authors:  Devin M Parker; Sherry L Owens; Niveditta Ramkumar; Donald Likosky; Anthony W DiScipio; David J Malenka; Todd A MacKenzie; Jeremiah R Brown
Journal:  Ann Thorac Surg       Date:  2019-07-20       Impact factor: 4.330

6.  Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Authors:  Casey M Rebholz; Elizabeth Selvin; Menglu Liang; Christie M Ballantyne; Ron C Hoogeveen; David Aguilar; John W McEvoy; Morgan E Grams; Josef Coresh
Journal:  Kidney Int       Date:  2017-08-31       Impact factor: 10.612

7.  Preoperative serum ST2 level predicts acute kidney injury after adult cardiac surgery.

Authors:  Kevin W Lobdell; Devin M Parker; Donald S Likosky; Michael Rezaee; Moritz Wyler von Ballmoos; Shama S Alam; Sherry Owens; Heather Thiessen-Philbrook; Todd MacKenzie; Jeremiah R Brown
Journal:  J Thorac Cardiovasc Surg       Date:  2018-04-11       Impact factor: 5.209

8.  Galectin-3 and the incidence of abdominal aortic aneurysm: the atherosclerosis risk in communities (ARIC) study.

Authors:  Oluwaseun E Fashanu; Aaron R Folsom; Abayomi Oyenuga; Christie M Ballantyne; Pamela L Lutsey; Weihong Tang
Journal:  Am J Cardiovasc Dis       Date:  2017-12-20

Review 9.  Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).

Authors:  Rui Dong; Min Zhang; Qunying Hu; Shan Zheng; Andrew Soh; Yijie Zheng; Hui Yuan
Journal:  Int J Mol Med       Date:  2017-12-05       Impact factor: 4.101

10.  ST2 Predicts Risk of Unplanned Readmission Within 1 Year After Pediatric Congenital Heart Surgery.

Authors:  Devin M Parker; Allen D Everett; Meagan E Stabler; Marshall L Jacobs; Jeffrey P Jacobs; Luca Vricella; Heather Thiessen-Philbrook; Chirag R Parikh; Cedric Manlhiot; Jeremiah R Brown
Journal:  Ann Thorac Surg       Date:  2020-04-01       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.